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Treatment options for children with end-stage heart failure are limited. We report the first 
case of a successful pediatric heart transplantation bridged with a durable left ventricu-
lar assist device in Korea. A 10-month-old female infant with dilated cardiomyopathy and 
left ventricular non-compaction was listed for heart transplantation. During the waiting 
period, the patient’s status deteriorated. Therefore, we decided to provide support with 
a durable left ventricular assist device as a bridge to transplantation. The patient was suc-
cessfully bridged to heart transplantation with effective support and without any major 
adverse events.
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Case report
Treatment options for children with end-stage heart fail-
ure are limited. Heart transplantation is the only viable 
option for these patients, and durable mechanical circula-
tory support is widely accepted as a bridge to transplanta-
tion despite the high rate of complications [1-3]. We report 
the first case of successful pediatric heart transplantation 
bridged with a durable pulsatile left ventricular assist de-
vice in Korea.
A 10-month-old female infant was referred to our hospi-
tal for severe cardiomegaly. She had presented to her pri-
mary care physician with symptoms of poor oral intake 
and lethargy lasting for a month. She became very lethar-
gic during the examination by the primary care physician 
and was promptly transferred to our cardiac intensive care 
unit for evaluation of the cardiogenic cause. The patient’s 
initial vital signs were as follows: blood pressure, 110/63 
mm Hg; heart rate, 159 beats/min; and respiratory rate, 54 
breaths/min. A chest X-ray examination revealed marked 
cardiomegaly (Fig. 1). On an echocardiographic examina-
tion, the left ventricular ejection fraction was estimated as 
13%, and severe dilatation of the left ventricle and the left 
atrium was noted, which was consistent with dilated car-
diomyopathy. A tricuspid annular plane systolic excursion 
of 11 mm, a tissue Doppler imaging–derived tricuspid lat-
eral annular systolic velocity of 8 cm/sec, and trivial tricus-
pid regurgitation suggested a mild degree of right ventric-
ular dysfunction. The sponge-like features of the left 
ventricular myocardium suggested left ventricular non- 
compaction. Medications including an angiotensin-con-
verting enzyme inhibitor, an aldosterone antagonist, and a 
beta-blocker were administered along with intravenous 
milrinone. The patient partly recovered from her lethargic 
condition, but tachypnea and activity limitation persisted. 
The patient’s left ventricular ejection fraction slightly im-
proved to 20%. Because her heart failure symptoms were 
refractory despite optimal medication, she was listed for 
heart transplantation. Because her blood type was O-posi-
tive, she was expected to have a long waiting period. After 
50 days of medical treatment, the patient’s condition dete-
riorated rapidly. She was intubated and mechanically ven-
tilated. Nevertheless, she was hypotensive and developed 
oliguria. Veno-arterial extracorporeal membrane oxygen-
ation (ECMO) was initiated via neck cannulation. After 3 
days of ECMO support, a left ventricular assist device was 
implanted with an extracorporeal pulsatile device (Berlin 





body surface area was 0.4 m2, and she was supported with 
a 15-mL pump. When performing apical cannulation of 
the left ventricle, a thorough and extensive resection of the 
trabeculation was performed to address left ventricular 
non-compaction. A 9-mm apical cannula was fixed to the 
apical hole with multiple interrupted stitches with an au-
tologous pericardial strip. For outflow graft connection, a 
short, 10-mm expanded polytetrafluoroethylene tube graft 
was anastomosed to the ascending aorta with partial 
clamping on the beating heart, and the outf low cannula 
was connected to the graft. Two silk ties were used to fix 
the cannula to the graft. Anticoagulation therapy with 
heparin was started 24 hours after the operation, and ace-
tylsalicylic acid was initiated on postoperative day 3. On 
post-implantation day 6, delayed mediastinal bleeding was 
noted, and the hematoma compressing the right atrium 
was surgically removed. Bleeding from a needle hole was 
observed at the aortic graft anastomosis site. The patient 
recovered uneventfully and was managed in the general 
ward from postoperative day 8 onwards (Fig. 2). Anticoag-
ulation therapy was maintained with warfarin, acetylsali-
cylic acid, and clopidogrel at a target international normal-
ized ratio range of 3.0–4.0. The pump was checked for 
abnormal membrane motion and thrombi by the nursing 
team every 2 hours. On post-implantation day 24, the pa-
tient underwent heart transplantation from a 5-year-old 
donor with a body weight of 29 kg. The total ischemic time 
was 192 minutes. The transplanted heart was oversized for 
the patient, but she recovered without any evidence of hy-
perperfusion syndrome. She was able to be weaned from 
mechanical ventilation on postoperative day 4 and was dis-
charged home on postoperative day 25. She is doing well, 
and has not shown any rejection episodes over the course 
of 6 months.
The parent of this patient provided written informed 
consent for the publication of clinical details and images.
Discussion
In small children and infants with end-stage heart fail-
ure, heart transplantation is the only long-term treatment 
option. However, waitlist mortality is high because of the 
scarcity of heart donors. According to the data collected 
from the United States registry, during 6 months after be-
ing listed for heart transplantation, 23% of patients died on 
the waiting list [4]. Although the total number of trans-
plantations has not increased, the number of pediatric 
heart transplantations that are bridged with ventricular as-
sist devices is increasing worldwide [5,6]. Post-transplant 
outcomes in patients after ventricular assist device support 
are similar to those of medically supported patients and 
are superior to that of patients treated with ECMO [7]. In 
Korea, the number of pediatric heart transplantations re-
mains low, with less than 20 transplants a year, and the 
frequency of transplantations in young children and in-
fants is especially low [8]. Until recently, mechanical circu-
latory support for children in Korea was most often pro-
vided by temporary support via ECMO. However, time 
limitations due to possible thromboembolic and hemor-
rhagic complications are a major drawback of ECMO. The 
Fig. 1. Initial chest radiography demonstrated marked cardiomeg-
aly and pulmonary congestion.
Fig. 2. Chest radiography after Berlin Heart EXCOR (Berlin Heart 
GmbH, Berlin, Germany) implantation.
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Berlin Heart EXCOR (Berlin Heart GmbH) is a paracorpo-
real, pneumatically-driven pulsatile pump device that is 
available with chambers of various stroke volumes. It is the 
most frequently used device in infants with end-stage heart 
failure as a bridge to transplantation [6]. The success rate 
of bridging to transplantation ranges from 37% to 72.5% 
[9].
The present case is the first successful pediatric heart 
transplantation bridged with the Berlin Heart EXCOR 
(Berlin Heart GmbH) in Korea. The severely decompensat-
ed infant was successfully switched from ECMO to a dura-
ble ventricular assist device and underwent transplantation 
safely. Frequent cerebrovascular complications have been 
reported with the Berlin Heart EXCOR (Berlin Heart 
GmbH) [10]. In this case, the patient received warfarin and 
dual antiplatelet therapy, and was free of any neurologic 
events. However, this case does not provide sufficient in-
formation on the effect of the Berlin Heart EXCOR (Berlin 
Heart GmbH) on growth and development due to the short 
duration of support. Considering that coverage by the Na-
tional Health Insurance Service for the Berlin Heart EX-
COR (Berlin Heart GmbH) was approved in 2018, we expect 
an increase in the number of pediatric heart transplanta-
tions bridged by durable ventricular assist devices in the 
future.
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